Status:
COMPLETED
Trial of Zinc and HIV Progression in Children
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
Thrasher Research Fund
Muhimbili University of Health and Allied Sciences
Conditions:
HIV Infections
Eligibility:
All Genders
6-60 years
Phase:
PHASE3
Brief Summary
To examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression, and improves growth.
Detailed Description
The purpose of this study is to examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression...
Eligibility Criteria
Inclusion
- HIV Infected Children under 60 months of age presenting at HIV treatment clinics in Dar es Salaam, Tanzania
Exclusion
- Eligible for ART: CD4 cell counts \< 20% or above pediatric clinical stage of HIV disease 3 according to WHO staging system.
- Severe acute malnutrition; Major congenital malformations
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT00446758
Start Date
March 1 2008
End Date
March 1 2009
Last Update
September 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muhimbili University College of Health Sciences
Dar es Salaam, Tanzania